I am finding a massive down-regulation of XBP1-dependent activity in cerebellum homogenates in one of my experiments. The activity of 37 of the 43 genes in my data set that are directly regulated by XBP1 are decreased. I understand that XBP1 is related to ER stress and is also involved in MHCII folding. However, I am fairly certain that my treatment is causing an increase in oxidative stress in the brain. I would expect XBP1-dependent activity would go up to clean up the mess associated with oxidative damage. So why would XBP1-regulated activity be turned off?
I am using the Affy Mouse ST 1.0 gene expression array, CARMAweb for the fold change/p value analysis, and IPA for pathway/upstream regulator analysis.